
Frontiers in Oncology, Journal Year: 2023, Volume and Issue: 13
Published: June 16, 2023
EDITORIAL article Front. Oncol., 16 June 2023Sec. Pediatric Oncology Volume 13 - 2023 | https://doi.org/10.3389/fonc.2023.1229197
Language: Английский
Frontiers in Oncology, Journal Year: 2023, Volume and Issue: 13
Published: June 16, 2023
EDITORIAL article Front. Oncol., 16 June 2023Sec. Pediatric Oncology Volume 13 - 2023 | https://doi.org/10.3389/fonc.2023.1229197
Language: Английский
Biomedicine & Pharmacotherapy, Journal Year: 2024, Volume and Issue: 178, P. 117181 - 117181
Published: July 25, 2024
Language: Английский
Citations
12Journal of Translational Medicine, Journal Year: 2023, Volume and Issue: 21(1)
Published: May 6, 2023
Abstract Infantile hemangioma (IH) is the most prevalent benign vascular tumor in infants, with distinct disease stages and durations. Despite fact that majority of IHs can regress spontaneously, a small percentage cause disfigurement or even be fatal. The mechanisms underlying development IH have not been fully elucidated. Establishing stable reliable models provides standardized experimental platform for elucidating its pathogenesis, thereby facilitating new drugs identification effective treatments. Common include cell suspension implantation model, viral gene transfer tissue block transplantation recent three-dimensional (3D) microtumor model. This article summarizes research progress clinical utility various models, as well benefits drawbacks each. Researchers should select based on their individual objectives to achieve anticipated objectives, increasing relevance findings.
Language: Английский
Citations
12Cell & Bioscience, Journal Year: 2024, Volume and Issue: 14(1)
Published: Feb. 10, 2024
Abstract Background Neovascular eye disease is characterized by pathological neovascularization, with clinical manifestations such as intraocular exudation, bleeding, and scar formation, ultimately leading to blindness in millions of individuals worldwide. Pathologic ocular angiogenesis often occurs common fundus diseases including proliferative diabetic retinopathy (PDR), age-related macular degeneration (AMD), prematurity (ROP). Anti-vascular endothelial growth factor (VEGF) targets the core pathology angiogenesis. Main body In recent years, therapies targeting metabolism prevent have also rapidly developed, offering assistance patients a poor prognosis while receiving anti-VEGF therapy reducing side effects associated long-term VEGF usage. Phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3), key enzyme targeted metabolism, has been shown great potential, antiangiogenic multiple protective treatment neovascular disease. this review, we summarize mechanisms types diseases; discuss effect potential mechanism PFKFB3, related inhibitors PFKFB3; look forward future exploration directions therapeutic prospects PFKFB3 Conclusion disease, most severely debilitating retinal largely incurable, necessitating new methods. possess various treating With development several drugs their gradual entry into research, PFKFB3-mediated glycolysis emerged promising approach for
Language: Английский
Citations
5Biochemical and Biophysical Research Communications, Journal Year: 2025, Volume and Issue: 752, P. 151469 - 151469
Published: Feb. 10, 2025
Language: Английский
Citations
0International Journal of Molecular Sciences, Journal Year: 2025, Volume and Issue: 26(6), P. 2386 - 2386
Published: March 7, 2025
Angiogenesis, the process by which new blood vessels emerge from pre-existing vasculature, forms fundamental biological basis for therapeutic angiogenesis. In recent years, this field has garnered significant attention, particularly in context of understanding mechanisms angiogenesis through lens glycometabolism. The potential clinical applications research have been widely acknowledged within medical community. article, role and principal molecular that govern it are first delineated. influence glycometabolism on is then explored, with a focus glycolysis. Finally, based regulation presented, offering novel perspectives ongoing applications.
Language: Английский
Citations
0Frontiers in Cell and Developmental Biology, Journal Year: 2025, Volume and Issue: 13
Published: May 14, 2025
Hepatoblastoma (HB), the most common pediatric liver malignancy, is characterized by aggressive growth and metastasis driven complex angiogenic mechanisms. This review elucidates pivotal role of angiogenesis in HB progression, emphasizing metabolic reprogramming, tumor microenvironment (TME) dynamics, oncogenic signalling pathways. The Warburg effect cells fosters a hypoxic microenvironment, stabilizing hypoxia-inducible factor-1α (HIF-1α) upregulating vascular endothelial factor (VEGF), which synergistically enhances angiogenesis. Key pathways such as Wnt/β-catenin, VEGF, PI3K/AKT, JAK2/STAT3 are central to cell proliferation, migration, maturation, whereas interactions with tumor-associated macrophages (TAMs) pericytes further remodel TME support neovascularization. Long noncoding RNAs glycolytic enzymes have emerged critical regulators angiogenesis, linking activity expansion. Anti-angiogenic therapies, including VEGF inhibitors pathway-targeting agents, show preclinical promise but face challenges resistance off-target effects. Future directions advocate for dual-target strategies, spatial multiomics technologies map metabolic–angiogenic crosstalk, personalized approaches leveraging biomarkers risk stratification. synthesis underscores need interdisciplinary collaboration translate mechanistic insights into durable ultimately improving outcomes patients.
Language: Английский
Citations
0Pediatric Research, Journal Year: 2025, Volume and Issue: unknown
Published: May 17, 2025
Language: Английский
Citations
0Discovery Medicine, Journal Year: 2024, Volume and Issue: 36(183), P. 678 - 678
Published: Jan. 1, 2024
An imbalance in energy metabolism serves as a causal factor for type 2 diabetes (T2D). Although metformin has been known to ameliorate the overall imbalance, but direct correlation between and central carbon (CCM) not thoroughly investigated. In this study, we employed high-performance ion chromatography-tandem mass spectrometry (HPIC-MS/MS) technique examine alterations significance of CCM both before after treatment T2D.
Language: Английский
Citations
3Pediatric Health Medicine and Therapeutics, Journal Year: 2024, Volume and Issue: Volume 15, P. 1 - 16
Published: Jan. 1, 2024
Abstract: Hemangiomas are vascular tumors resulting from the proliferation of endothelial-like cells; they most common childhood tumors, affecting approximately 5– 10% newborns and infants. Besides hemangiomas, which definitely benign despite their overgrowth potential, there other like hemangioendotheliomas, may display intermediate characteristics between hemangiomas highly malignant angiosarcomas. Standard therapy be constricted by serious adverse effects, high cost, or traumatic influence. Diet is a major resource for health preservation, disease prevention, treatment. The therapeutic property edible berries, marine products, medicinal plants have long been known used in traditional medicine; plant-based nutrition can prevent development progression diseases associated with extensive neo-vascularization. purpose our review to highlight those natural treatments that hemangioma tumor patients receive future, both benefit families. We performed according Preferred Reporting Items Systematic Reviews Metanalysis Statement. Web Science, PubMed, EMBASE engines study, searched association naturopathic treatment/plant extract/plants published articles. found extracts fruits cost-effective safe as well forms cancer. In any case, more vitro vivo studies needed confirm proposed signaling pathways validate improvement parameters after products administration. era molecularly targeted personalized medicine approaching naturally occurring substances very useful tools treatment prevention. Plant extract strong specificity pertinence, non- toxic few side become an emerging cancer Keywords: abnormalities, plants, plant extract,
Language: Английский
Citations
2Journal of Environmental Pathology Toxicology and Oncology, Journal Year: 2024, Volume and Issue: 43(4), P. 53 - 64
Published: Jan. 1, 2024
Ovarian cancer is one of the most common malignant tumors in female reproductive organs. Its incidence rate second only to uterine body and cervical cancer, posing a serious threat women's health. Herein, we explored that PFKFB3 progression ovarian its underlying mechanism. All serum samples from were collected by our hospital. mRNA expressions patients with cell lines up-regulated. protein cells induced. high PFKFB3expression had lower survival rate. The PFKFB3gene promoted proliferation EDU cells, increased metastasis cancer. Si-PFKFB3 reduced decreased gene up-regulation caspase-3/9 activity levels also Warburg effect NLRP3-induced pyroptosis suppressed NLRP3 expression. was target spot for on Taken together, conclude axis reduce increase provide molecular insight into mechanisms which regulates
Language: Английский
Citations
2